These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 5058425)
1. [Drug therapy of pulmonary tuberculosis]. Ludes H Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425 [No Abstract] [Full Text] [Related]
2. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
3. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy]. Freerksen E Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222 [No Abstract] [Full Text] [Related]
5. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)]. Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253 [No Abstract] [Full Text] [Related]
6. [Place of bacteriological examination in the treatment of tuberculosis]. Gyselen A Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438 [No Abstract] [Full Text] [Related]
7. Initial treatment of tuberculosis with rifampicin. O'Connell J; Campbell AH; Cowen K; Verins A Med J Aust; 1973 Nov; 2(19):881-5. PubMed ID: 4765873 [No Abstract] [Full Text] [Related]
8. [The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations]. Kindler U; Derichs R; Merholz S Med Welt; 1976 Feb; 27(8):387-8. PubMed ID: 1256307 [No Abstract] [Full Text] [Related]
9. Drugs in the treatment of tuberculosis--1969. Beacham EG Johns Hopkins Med J; 1969 Nov; 125(5):286-90. PubMed ID: 5366128 [No Abstract] [Full Text] [Related]
11. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)]. Bignall JR Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016 [No Abstract] [Full Text] [Related]
14. [Mode of action of "tuverculostatics". Consequences for the therapy]. Krebs A Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006 [No Abstract] [Full Text] [Related]
15. [Combined antitubercular treatment of pulmonary tuberculosis in adults]. Böszörményi M Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914 [No Abstract] [Full Text] [Related]
16. [Internal medicine treatment of pulmonary tuberculosis]. Schaich W Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072 [No Abstract] [Full Text] [Related]
17. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis]. Knop P; Kindler U; Merholz T Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308 [No Abstract] [Full Text] [Related]
18. The predictability of hypersensitivity to anti-tuberculous drugs. Thompson JE Aust N Z J Med; 1973 Jun; 3(3):239-44. PubMed ID: 4517219 [No Abstract] [Full Text] [Related]
19. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated]. Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547 [No Abstract] [Full Text] [Related]
20. [New drugs in antitubercular therapy]. Favez G Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509 [No Abstract] [Full Text] [Related] [Next] [New Search]